SynAct Pharma AB: ifrs:InterestReceivedClassifiedAsOperatingActivities
| Value | {"amount": 778000.0} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | SynAct Pharma AB |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T23:08:31.956949+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/12118b2a-f379-488f-8d95-a95b9eab0d83
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:549300RRYIEFEQ72N546:2024-12-31Retrieved: 2026-08-23T23:08:31.956949+02:00
Raw response sha256:
af35ad3a3d080a3bf3479d6c365af862…Cite as: FACTANKER, https://factanker.com/fact/12118b2a-f379-488f-8d95-a95b9eab0d83
History
- no predecessors — first report